Oral Cancer Clinical Trial
— VADSOfficial title:
Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective Study
Context: the oral cancer is the 5th cancer in order of frequency for human in France. It is
the country where the mortality by oral cancer is the most raised in Europe. The most
frequent location concerns the oral cavity prevalency of which is one of higher in the
world. The main risk factors are the tobacco and the alcohol.
The oral cancer is treated in the great majority of the cases by radiotherapy which is going
to pull xerostomy, responsible for the degradation of the oral state. Furthermore, it will
increase the risk of appearance of osteoradionecrosis (ORN) when the patient is carrier of
buccal lesions and\or when he will have to undergo surgical acts. Consequently, the initial
oral state of the patients is to be estimated so as to eliminate any source of the
infection. An unfavourable initial state will increase the risk of degradation of this one
and appearance of ORN. However, at present few epidemiological data are available concerning
the oral state of the patients presenting an oral cancer.
Objective: the main objective of this study is to describe, before radiotherapy, the oral
state of the patients presenting an oral cancer and to follow the evolution of this oral
state for three years and to register the patients quality of life. The secondary objectives
are to describe the distribution of risk factors of the degradation of the oral state (oral
hygiene, food habits, xerostomy, consumption of tobacco and alcohol) in this population and
to register the impact of the dental restorations on the radiological assessment.
Methods: this prospective epidemiological study of observation will be realized in the
service of odontology of the Timone hospital (Marseille, France) in association with the
services of ORL and maxillofacial surgery of Timone as well as the services of radiotherapy
and medical oncology of Timone and Paoli Calmettes institute (IPC). All the toothed patients
affected by an oral cancer untreated will be included, or treated surgically only, of more
than 18 years old and for whom an initial dental assessment will be realized. The main
assessment criteria will be the CAD index and the parodontal state.
Expected results and perspectives: This study will allow to have epidemiological data
concerning patients' oral state affected by an oral cancer before and after radiotherapy. It
will allow to set up a consensus of good practice.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | January 2019 |
Est. primary completion date | January 2018 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient with a first oral cancer - Patient with teeth - Patient not yet treated for the oral cancer Exclusion Criteria: - Patient with a cancer already treated or with an oral cancer ongoing treatment. - Patient without teeth - Patient with trouble for comprehention and without capabilities for brushing teeth |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
France | Assistance Publique Hôpitaux de Marseille | Marseille |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique Hopitaux De Marseille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of changes in pain score using CTCAE v4.0 scale | Units on scales of CTCAE v4.0 | 6 Weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06031337 -
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
|
||
Completed |
NCT00158678 -
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
Phase 3 | |
Completed |
NCT00933387 -
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT05030597 -
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Recruiting |
NCT03684707 -
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
|
Phase 4 | |
Recruiting |
NCT06130332 -
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
|
Phase 2 | |
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Recruiting |
NCT03686020 -
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
|
||
Not yet recruiting |
NCT06060288 -
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
|
||
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Completed |
NCT01418118 -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00232960 -
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Completed |
NCT04614896 -
Use of Ultrasound for Measuring Size of Oral Tongue Cancers
|
N/A | |
Recruiting |
NCT03685409 -
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
|
Phase 3 | |
Completed |
NCT00402779 -
Erlotinib Prevention of Oral Cancer (EPOC)
|
Phase 3 | |
Recruiting |
NCT05153733 -
Improved Implant for Reconstruction Purposes After Mandibular Resection
|
N/A |